CS logo
small CS logo
Queen Mary Hospital

Hong Kong, Hong Kong
Hospital in Hong Kong
Queen Mary Hospital Main Block, Pok Fu Lam Rd, Pok Fu Lam
1,711 Beds

About Queen Mary Hospital


The Queen Mary Hospital, located in Pok Fu Lam on Hong Kong Island of Hong Kong, is the public district general hospital and teaching hospital of the Faculty of Dentistry and Li Ka Shing Faculty of Medicine of the University of Hong Kong. It has 1,706 beds.
There are 1,711 beds in Queen Mary Hospital.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
The University of Hong Kong
174
Hospital Authority, Hong Kong
25
Pfizer
18
Boehringer Ingelheim
17
Hoffmann-La Roche
17
Gilead Sciences
15
Boston Scientific Corporation
12
Abbott Medical Devices
9
Bayer
8
Chinese University of Hong Kong
6
Janssen Research & Development, LLC
6
Total Rows: 100

Clinical Trials at Queen Mary Hospital


During the past decade, Queen Mary Hospital conducted 316 clinical trials. In the 10-year time frame, 316 clinical trials started and 92 clinical trials were completed, i.e. on average, 29.1% percent of trials that started reached the finish line to date. In the past 5 years, 134 clinical trials started and 49 clinical trials were completed. i.e. 36.6% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years30303232333349493838575749492727119955111144141415151919111144Started TrialsCompleted Trails2015201620172018201920202021202220230255075
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach
1995-03-01
Unknown status
200
Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer
2001-10-29
2009-02-10
Completed
569
OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
2001-11-01
2004-01-30
Completed
731
Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma.
2002-07-01
Unknown status
35
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
2001-11-01
2015-06-01
Completed
5,099
T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients
2003-03-01
Terminated
750
Study of LJP 394 in Lupus Patients With History of Renal Disease
2004-10-01
2009-02-01
Terminated
943
Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II
2004-04-01
2011-02-01
Completed
185

Rows per page:

1–100 of 512

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Queen Mary Hospital" #1 sponsor was "The University of Hong Kong" with 174 trials, followed by "Hospital Authority, Hong Kong" with 25 trials sponsored, "Pfizer" with 18 trials sponsored, "Boehringer Ingelheim" with 17 trials sponsored and "Hoffmann-La Roche" with 17 trials sponsored. Other sponsors include 256 different institutions and companies that sponsored additional 148 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Mary Hospital" #1 collaborator was "Queen Mary Hospital, Hong Kong" with 21 trials as a collaborator, "The University of Hong Kong" with 18 trials as a collaborator, "United Christian Hospital" with 8 trials as a collaborator, "Kwong Wah Hospital" with 7 trials as a collaborator and "Pamela Youde Nethersole Eastern Hospital" with 6 trials as a collaborator. Other collaborators include 203 different institutions and companies that were collaborators in the rest 171 trials.
Created with Highcharts 11.1.0Top Leading SponsorsThe University of HongKong: 174The University of HongKong: 174Hospital Authority,Hong Kong: 25Hospital Authority,Hong Kong: 25Pfizer: 18Pfizer: 18Boehringer Ingelheim: 17Boehringer Ingelheim: 17Hoffmann-La Roche: 17Hoffmann-La Roche: 17Gilead Sciences: 15Gilead Sciences: 15Boston Scientific Corporation: 12Boston Scientific Corporation: 12Abbott Medical Devices: 9Abbott Medical Devices: 9Bayer: 8Bayer: 8Chinese University ofHong Kong: 6Chinese University ofHong Kong: 6

Created with Highcharts 11.1.0Top CollaboratorsQueen Mary Hospital,Hong Kong: 21Queen Mary Hospital,Hong Kong: 21The University of Hong Kong: 18The University of Hong Kong: 18United Christian Hospital: 8United Christian Hospital: 8Kwong Wah Hospital: 7Kwong Wah Hospital: 7Pamela YoudeNethersole EasternHospital: 6Pamela YoudeNethersole EasternHospital: 6Hospital Authority, Hong Kong: 5Hospital Authority, Hong Kong: 5Gilead Sciences: 4Gilead Sciences: 4Princess MargaretHospital, Hong Kong: 4Princess MargaretHospital, Hong Kong: 4Queen ElizabethHospital, Hong Kong: 4Queen ElizabethHospital, Hong Kong: 4AstraZeneca: 3AstraZeneca: 3

Clinical Trials Conditions at Queen Mary Hospital


According to Clinical.Site data, the most researched conditions in "Queen Mary Hospital" are "Chronic Hepatitis B" (15 trials), "Hepatocellular Carcinoma" (15 trials), "Hepatitis B" (10 trials), "Stroke" (9 trials) and "Lung Cancer" (8 trials). Many other conditions were trialed in "Queen Mary Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Queen Mary Hospital


Most popular intervention types in "Queen Mary Hospital" are "Drug" (290 trials), "Device" (86 trials), "Other" (66 trials), "Biological" (36 trials) and "Procedure" (30 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (59 trials), "Capecitabine" (8 trials), "Cisplatin" (8 trials), "Pembrolizumab" (8 trials) and "Carboplatin" (6 trials). Other intervention names were less common.

Clinical Trials Genders at Queen Mary Hospital


The vast majority of trials in "Queen Mary Hospital" are 464 trials for "All" genders, 39 trials for "Female" genders and 9 trials for "Male" genders.

Clinical Trials Status at Queen Mary Hospital


Currently, there are 162 active trials in "Queen Mary Hospital". 3 are not yet recruiting, 91 are recruiting, 64 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 235 completed trials in Queen Mary Hospital, 2 suspended trials, and 42 terminated clinical trials to date.
Out of the total trials that were conducted in Queen Mary Hospital, 44 "Phase 1" clinical trials were conducted, 114 "Phase 2" clinical trials and 127 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 34 trials, and there were also 146 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhaseNot Applicable: 146Not Applicable: 146Phase 3: 127Phase 3: 127Phase 2: 114Phase 2: 114Phase 1: 44Phase 1: 44Phase 4: 34Phase 4: 34

Created with Highcharts 11.1.0Trials StatusCompleted: 235Completed: 235Recruiting: 91Recruiting: 91Unknown status: 70Unknown status: 70Active, not recruiting: 64Active, not recruiting: 64Terminated: 42Terminated: 42Enrolling by invitation: 4Enrolling by invitation: 4Not yet recruiting: 3Not yet recruiting: 3Suspended: 2Suspended: 2Withdrawn: 1Withdrawn: 1

Departments of Queen Mary Hospital


Queen Mary Hospital has several departments that took part in Clinical trials: "Department of Anaesthesia and Intensive Care, New Territories West Cluster, Hospital Authority" - 2 trials